Complete HOOK Stock Valuation Analysis

Comprehensive intrinsic value analysis using 2 different methodologies

HOOK DCF Analysis

HOOK (HOOKIPA Pharma Inc.) discounted cash flow analysis with multiple scenarios, growth assumptions, and terminal value calculations

Financial Projections

WACC Calculation

Weighted Average Cost of Capital used for discounting cash flows.

Terminal Value

Choose between perpetuity growth or exit multiple methods.

Valuation Summary
$25.62
Implied Price
$1.60
Current Price
+1501.5%
Upside/Downside
8.4%
WACC

HOOK Peer Valuation Analysis

Relative valuation based on comparable company trading multiples

Peer Valuation Analysis

Fair Value Range Analysis

Based on median multiples from 9 peer companies in Healthcare

P/E Ratio
$-338.26
-21241.4%
Peer Median: 55.6x
EV/EBITDA
$0.00
-100.0%
Peer Median: 0.0x
P/S Ratio
$1.60
+0.0%
Peer Median: 2.7x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for HOOK's business model and current situation.
Multiple Comparison
MultipleHOOK CurrentPeer MedianPeer AveragePremium/DiscountAssessment
P/E Ratio-0.3x55.6x27.9x-100.5%
Undervalued
EV/EBITDA-Infinityx0.0x0.0x-Infinity%
Undervalued
P/S Ratio2.7x2.7x4.6x0.0%
Fair Value
Peer Companies
Click any company to view their valuation
CompanyMarket CapP/E RatioEV/EBITDAP/S Ratio
$0.02B0.1x0.0x0.7x
$0.04B0.0x0.0x48.2x
$0.02B0.0x0.0x8.0x
$0.02B55.6x0.0x0.7x
$0.02B0.0x0.0x0.0x
$0.02B0.0x0.0x2.7x
$0.02B0.0x0.0x0.0x
$0.02B0.0x0.0x11.0x
$0.02B0.0x0.0x46.2x